Tobias Ruck Selected Research

Tobias Ruck Research Topics

Disease

31	Multiple Sclerosis 08/2022 - 07/2014
12	Relapsing-Remitting Multiple Sclerosis 03/2022 - 07/2015
8	Neuroinflammatory Diseases 01/2022 - 07/2014
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 03/2011
5	Infections 08/2022 - 07/2018
5	Myasthenia Gravis 04/2022 - 01/2019
5	Deglutition Disorders (Dysphagia) 01/2021 - 01/2019
5	Inflammation (Inflammations) 11/2019 - 08/2014
4	Myositis (Idiopathic Inflammatory Myopathies) 11/2022 - 08/2010
3	Demyelinating Diseases (Demyelinating Disease) 10/2022 - 07/2014
3	Lymphopenia (Lymphocytopenia) 08/2022 - 01/2016
3	Disease Progression 07/2022 - 01/2022
3	Encephalomyelitis (Myeloencephalitis) 06/2020 - 07/2014
2	Virus Diseases (Viral Diseases) 02/2022 - 01/2021
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2021
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2020
2	Exanthema (Rash) 08/2021 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 12/2018
2	Rheumatoid Arthritis 05/2021 - 07/2015
2	COVID-19 01/2021 - 06/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 09/2013
2	Cognitive Dysfunction 01/2017 - 01/2017
2	Polymyositis 12/2015 - 03/2015
1	Muscular Diseases (Myopathy) 11/2022
1	Absence Epilepsy (Childhood Absence Epilepsy) 10/2022
1	Thymoma (Thymic Carcinoma) 04/2022
1	Blood Vessel Dissection 03/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2022
1	Hemorrhage 03/2022
1	Hemorrhagic Stroke 03/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Inclusion Body Myositis 01/2022
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2022
1	Glomerulonephritis 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 09/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2021
1	Muscle Weakness 08/2021
1	Muscular Atrophy (Muscle Atrophy) 08/2021
1	Retroviridae Infections (Infection, Retrovirus) 01/2021
1	Dermatomyositis (Dermatopolymyositis) 01/2021
1	Erythema elevatum diutinum 01/2021
1	Pruritus (Itching) 01/2021
1	Alopecia Areata 01/2021
1	Mucositis 01/2021
1	Hashimoto's encephalitis 01/2021
1	Sudden Infant Death (SID) 01/2021
1	Neoplasms (Cancer) 07/2020
1	Leukocytosis (Pleocytosis) 06/2020
1	Transverse Myelitis (Necrotizing Myelitis) 06/2020
1	Neuromyelitis Optica (Devic's Disease) 06/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Sinusitis 01/2020

Drug/Important Bio-Agent (IBA)

18	Alemtuzumab (Campath)FDA Link 03/2022 - 03/2015
5	AntibodiesIBA 11/2022 - 01/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2013
4	CytokinesIBA 10/2022 - 07/2014
4	Cladribine FDA LinkGeneric 08/2022 - 01/2021
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2011
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
3	AutoantibodiesIBA 07/2020 - 01/2019
2	CuprizoneIBA 10/2022 - 01/2021
2	eculizumab FDA Link 01/2022 - 01/2021
2	ocrelizumabIBA 01/2022 - 01/2021
2	Ligases (Synthetase)IBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 06/2020 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 11/2019 - 01/2016
2	Neuroprotective AgentsIBA 11/2019 - 01/2018
2	Natalizumab (Tysabri)FDA Link 01/2019 - 01/2017
2	Monoclonal AntibodiesIBA 01/2019 - 07/2015
2	Substance PIBA 01/2019 - 01/2017
2	Peptides (Polypeptides)IBA 07/2014 - 09/2013
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 10/2022
1	2'-deoxyadenosineIBA 08/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2022
1	Dimethyl FumarateIBA 02/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	nitroxolineIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 09/2021
1	Vitamin E FDA LinkGeneric 09/2021
1	Dystroglycans (Dystroglycan)IBA 08/2021
1	Methotrexate (Mexate)FDA LinkGeneric 08/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021
1	Ion Channels (Ion Channel)IBA 05/2021
1	AnionsIBA 05/2021
1	Edrophonium (Tensilon)FDA LinkGeneric 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	teriflunomideIBA 01/2021
1	GadoliniumIBA 06/2020
1	Oligoclonal BandsIBA 06/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020

Therapy/Procedure

17	Therapeutics 07/2022 - 07/2015
3	Immunotherapy 01/2022 - 06/2020
2	Blood Component Removal (Apheresis) 10/2019 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 04/2022
1	Immunomodulation 01/2022